Skip to main content

Want a detailed portfolio tracker?

Polypid (PYPD) P/E (2020 - 2026)

Polypid (PYPD) P/E from Dec 31, 2020 to Jun 3, 2026. The TTM Polypid (PYPD) P/E is -2.51. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Polypid (PYPD)

YearP/EChange
2026-2.51+8.76%
2025-2.31+116.58%
2024-1.07-36.19%
2023-1.67-81.84%
2022-9.21-87.85%
2021-75.82-49.11%
2020-148.98N/A

Comparison Polypid (PYPD) P/E with competitors

Polypid (PYPD) P/E is -2.51.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.10-104.07%
ENLVEnlivex Therapeutics Ltd0.15-105.97%
FGENFibroGen Inc0.24-109.55%
TRAWTraws Pharma Inc0.47-118.80%
FBIOFortress Biotech Inc0.71-128.08%
CHRSCoherus Biosciences Inc0.98-138.90%
ORMPOramed Pharmaceuticals Inc1.47-158.59%
AGENAgenus Inc2.05-181.46%
VIVSVivoSim Labs Inc2.54-200.84%
INVAInnoviva Inc3.19-226.80%
CRMDCorMedix Inc3.65-244.98%
ABEOAbeona Therapeutics Inc4.20-267.22%
VXRTVaxart Inc4.26-269.47%
CVACCureVac N.V.4.45-276.79%
SRPTSarepta Therapeutics Inc4.62-283.89%
GLPGGalapagos NV4.86-293.22%
RIGLRigel Pharmaceuticals4.92-295.64%
ZVRAZevra Therapeutics Inc4.97-297.80%
ABUSArbutus Biopharma Corp5.69-326.42%
CGENCompugen Ltd7.38-393.64%
AUPHAurinia Pharmaceuticals Inc9.25-467.91%
ACADAcadia Pharmaceuticals Inc9.59-481.29%
OMEROmeros Corporation9.88-493.04%
PLXProtalix BioTherapeutics Inc9.91-494.06%
SPROSpero Therapeutics Inc10.73-526.90%
ADMAAdma Biologics Inc11.33-550.59%
SVASinovac Biotech Ltd11.44-554.79%
TBPHTheravance Biopharma Inc11.78-568.33%
HRMYHarmony Biosciences Holdings Inc12.18-584.39%
TGTXTG Therapeutics Inc13.18-624.12%
INCYIncyte Corp13.38-632.17%
SABSSAB Biotherapeutics Inc14.06-659.05%
XOMAXOMA Corp14.95-694.34%
REGNRegeneron Pharmaceuticals Inc14.98-695.73%
PBYIPuma Biotechnology Inc15.05-698.52%
EXELExelixis Inc15.79-728.13%
NAGENiagen Bioscience Inc16.35-750.40%
CPRXCatalyst Pharmaceuticals Inc17.34-789.76%
MDXGMimedx Group Inc17.38-790.98%
ARGXArgen X SE23.07-1017.51%
HALOHalozyme Therapeutics Inc23.20-1022.64%
XOMAOXOMA Corp25.34-1107.91%
VRTXVertex Pharmaceuticals Inc25.66-1120.28%
XOMAPXOMA Corp25.67-1120.85%
CTMXCytomX Therapeutics Inc25.70-1121.95%
ASNDAscendis Pharma A/S26.35-1148.05%
RPRXRoyalty Pharma plc - Class A27.50-1193.44%
SLNOSoleno Therapeutics Inc29.02-1253.88%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1300.46%
BMRNBiomarin Pharmaceutical Inc37.51-1591.59%
APLSApellis Pharmaceuticals Inc39.02-1651.79%
KRYSKrystal Biotech Inc39.70-1678.69%
GMABGenmab40.20-1698.81%
ONCBeiGene Ltd67.03-2765.52%
TECHBio-Techne Corp68.59-2827.88%
VCELVericel Corp80.63-3306.46%
PHARPharming Group N.V.87.74-3589.25%
ALNYAlnylam Pharmaceuticals Inc124.93-5068.36%
TLXTelix Pharmaceuticals Ltd139.89-5663.17%
CORTCorcept Therapeutics Inc158.39-6398.82%